E-LIB Suche - Ergebnisse für: Giles, Francis J. - Sprache DE

Personensuche X

Sortierung: Jahr

Sortierung: Relevanz

1

Efficacy and safety of bosutinib in patients treated with p..:

Smith, B. Douglas ; Brümmendorf, Tim H. ; Roboz, Gail J....
Leukemia Research. 139 (2024) - p. 107481 , 2024

Link: https://doi.org/10.1016/..

2

Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cam..:

Sachathep, Karampreet ; Duong, Yen T. ; Reid, Giles...
Influenza and Other Respiratory Viruses. 18 (2024) 4 - p. , 2024

Link: https://doi.org/10.1111/..

3

Supplementary Figure S1 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124799.v1. , 2024

Link: https://doi.org/10.1158/..

4

Supplementary Table S5 from Phase I Study of Elraglusib (9-..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124727.v1. , 2024

Link: https://doi.org/10.1158/..

5

Supplementary Figure S4 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124763.v1. , 2024

Link: https://doi.org/10.1158/..

6

Supplementary Table S5 from Phase I Study of Elraglusib (9-..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124727.v1. , 2024

Link: https://doi.org/10.1158/..

7

Supplementary Figure S8 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124751.v1. , 2024

Link: https://doi.org/10.1158/..

8

Supplementary Figure S8 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124751.v1. , 2024

Link: https://doi.org/10.1158/..

9

Supplementary Figure S13 from Phase I Study of Elraglusib (..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124787.v1. , 2024

Link: https://doi.org/10.1158/..

10

Supplementary Figure S4 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124763.v1. , 2024

Link: https://doi.org/10.1158/..

11

Supplementary Figure S2 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124769.v1. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Figure S6 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124757.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Figure S6 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124757.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Figure S2 from Phase I Study of Elraglusib (9..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124769.v1. , 2024

Link: https://doi.org/10.1158/..

15

Supplementary Table S6 from Phase I Study of Elraglusib (9-..:

Benedito A. Carneiro ; Ludimila Cavalcante ; Devalingam Mahalingam...
doi:10.1158/1078-0432.25124724.v1. , 2024

Link: https://doi.org/10.1158/..

1-15

Mehr Literatur finden